Literature DB >> 27162514

Management of Vesicoureteral Reflux by Endoscopic Injection of Dextranomer/Hyaluronic Acid in Adults.

Timothy W Stark1, John M Lacy2, David M Preston3.   

Abstract

A 74-year-old man presented for evaluation after discovery of a left bladder-wall tumor. He underwent transurethral resection of bladder tumor (TURBT) operation for treatment of low-grade, Ta urothelial cancer of the bladder. The patient developed recurrent disease and returned to the operating room for repeat TURBT, circumcision, and administration of intravesical mitomycin C. The patient developed balanitis xerotica obliterans 4 years post-circumcision, requiring self-dilation with a catheter. He subsequently developed 3 consecutive episodes of left-sided pyelonephritis. Further investigation with voiding cystourethrogram (VCUG) revealed Grade 3, left-sided vesicoureteral reflux (VUR). Due to existing comorbidities, the patient elected treatment with endoscopic dextranomer/hyaluronic acid injection. A post-operative VCUG demonstrated complete resolution of left-sided VUR. This patient has remained symptom free for 8 months post-injection, with no episodes of pyelonephritis.

Entities:  

Keywords:  Dextranomer/hyaluronic acid; Pyelonephritis; Vesicoureteral reflux

Year:  2016        PMID: 27162514      PMCID: PMC4859930     

Source DB:  PubMed          Journal:  Rev Urol        ISSN: 1523-6161


  10 in total

1.  Endoscopic management of vesicoureteral reflux in adult women.

Authors:  Alana M Murphy; Chad R Ritch; Elizabeth A Reiley; Terry W Hensle
Journal:  BJU Int       Date:  2010-11-11       Impact factor: 5.588

2.  Injectable dextranomer-based implant: histopathology, volume changes and DNA-analysis.

Authors:  A Stenberg; E Larsson; A Lindholm; B Ronneus; A Stenberg; G Läckgren
Journal:  Scand J Urol Nephrol       Date:  1999-12

3.  Treatment of vesicoureteral reflux in adults by endoscopic injection.

Authors:  Katherine Moore; Stéphane Bolduc
Journal:  Urology       Date:  2011-04-15       Impact factor: 2.649

4.  Endoscopic treatment of vesicoureteral reflux in an adult population: Can we teach our adult urology colleagues?

Authors:  Alaeddin Natsheh; Ofer Z Shenfeld; Amicur Farkas; Boris Chertin
Journal:  J Pediatr Urol       Date:  2010-03-02       Impact factor: 1.830

5.  Long-term followup of children treated with dextranomer/hyaluronic acid copolymer for vesicoureteral reflux.

Authors:  G Läckgren; N Wåhlin; E Sköldenberg; A Stenberg
Journal:  J Urol       Date:  2001-11       Impact factor: 7.450

6.  The deflux procedure reduces the incidence of urinary tract infections in patients with vesicoureteral reflux.

Authors:  George M Wadie; Michael V Tirabassi; Richard A Courtney; Kevin P Moriarty
Journal:  J Laparoendosc Adv Surg Tech A       Date:  2007-06       Impact factor: 1.878

7.  Endoscopic management of vesicoureteral reflux in women presenting with pyelonephritis.

Authors:  Zeph Okeke; Debra Fromer; Mark H Katz; Elizabeth A Reiley; Terry W Hensle
Journal:  J Urol       Date:  2006-11       Impact factor: 7.450

8.  Renal scarring and urinary tract infection after successful endoscopic correction of vesicoureteral reflux.

Authors:  Boris Chertin; Alaeddin Natsheh; Alon Fridmans; Ofer Z Shenfeld; Amicur Farkas
Journal:  J Urol       Date:  2009-08-18       Impact factor: 7.450

9.  Efficiency of endoscopic treatment for vesico-ureteric reflux in adults.

Authors:  Jacobo Arce; Oriol Angerri; Jorge Caffaratti; José Maria Garat; Humberto Villavicencio
Journal:  BJU Int       Date:  2008-10-31       Impact factor: 5.588

10.  Has the data efflux regarding the promising outcome following injection of deflux changed the management of adult vesicoureteral reflux?

Authors:  D E Zilberman; Y Mor
Journal:  Adv Urol       Date:  2009-03-10
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.